Media & Resources

IAVI’s strong presence at the TropMed conference will showcase the expansion of our emerging infectious diseases program and enable critical dialogue with our global health peers.

IAVI leaders will chair sessions and share the latest on our emerging infectious diseases program, vaccine innovation, and more at Europe’s largest vaccine conference.

Cross-disciplinary conversations highlighted recent progress in HIV vaccine and antibody research, as well as the importance of choice and community collaboration when developing HIV prevention strategies.

IAVI leaders to represent the full breadth of TB vaccine research, development, implementation, advocacy, and policy at the 7th Global Forum in Rio.

From HIV vaccine development to socio-behavioral research and community engagement in clinical trials, IAVI leaders are presenting on a range of pressing topics in HIV prevention research.

Researchers at three sites are vaccinating participants for Lassa fever, an emerging infectious disease with outbreaks in the region.

IAVI leaders will present on why we still need an HIV vaccine and how to engage communities in clinical trials and will launch an Action Plan for accelerating progress on broadly neutralizing antibodies for HIV prevention.

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team.